Vertex Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript
Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen. It's my pleasure to do a fireside chat with Vertex. We have Vertex's CEO, Reshma Kewalramani with us this morning. And as many of you know who follow our research, Vertex has been one of our favorite large caps for a long time. So we're happy to dive into the details once again at the Cowen Conference. Reshma, maybe I'll hand it over to you to begin.
Questions & Answers
Can you give us a state of the company statement? What are Vertex's strengths, its challenges? And what will it do to create shareholder value over the next year or two?
Sure. I think, well, good morning Phil, and good morning all. It's nice to be with all of you today. From a thumbnail sketch point of view for the company, we're at a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
